Chronisch Lymphatische Leukämie Guidline and Quality indicator
0.2.0 - ci-build
Chronisch Lymphatische Leukämie Guidline and Quality indicator - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2025-01-16 |
{
"resourceType" : "ActivityDefinition",
"id" : "CMVAntibodyIgMCLL",
"meta" : {
"profile" : [
🔗 "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/assessment-action"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ActivityDefinition CMVAntibodyIgMCLL</b></p><a name=\"CMVAntibodyIgMCLL\"> </a><a name=\"hcCMVAntibodyIgMCLL\"> </a><a name=\"CMVAntibodyIgMCLL-en-US\"> </a><p><b>knowledgeCapability</b>: computable</p><p><b>knowledgeRepresentationLevel</b>: structured</p><p><b>url</b>: <a href=\"ActivityDefinition-CMVAntibodyIgMCLL.html\">ActivityDefinition CMV IgM Antibody CLL</a></p><p><b>version</b>: Langversion 2.01</p><p><b>name</b>: CMVAntibodyIgMCLL</p><p><b>title</b>: CMV IgM Antibody CLL</p><p><b>status</b>: Active</p><p><b>experimental</b>: false</p><p><b>subject</b>: <span title=\"Codes:{http://hl7.org/fhir/fhir-types Patient}\">Patient</span></p><p><b>date</b>: 2025-01-16 09:02:23+0000</p><p><b>publisher</b>: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll</p><p><b>description</b>: </p><div><p>CMV IgM Antikörper Bestimmung</p>\n</div><p><b>kind</b>: ServiceRequest</p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 62681000237103}\">CMV (cytomegalovirus) IgM antibody in serum qualitative result</span></p><p><b>timing</b>: Count 1 times, Once</p></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
"valueCode" : "computable"
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
"valueCode" : "structured"
}
],
"url" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/CMVAntibodyIgMCLL",
"version" : "Langversion 2.01",
"name" : "CMVAntibodyIgMCLL",
"title" : "CMV IgM Antibody CLL",
"status" : "active",
"experimental" : false,
"subjectCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Patient"
}
]
},
"date" : "2025-01-16T09:02:23+00:00",
"publisher" : "https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll",
"description" : "CMV IgM Antikörper Bestimmung",
"kind" : "ServiceRequest",
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/83821000000107/version/20230412fd",
"code" : "62681000237103",
"display" : "CMV (cytomegalovirus) IgM antibody in serum qualitative result"
}
]
},
"timingTiming" : {
"extension" : [
{
"extension" : [
{
"url" : "contextCode",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "63936-9"
}
]
}
},
{
"url" : "offset",
"valueRange" : {
"low" : {
"value" : -4,
"system" : "http://unitsofmeasure.org",
"code" : "wk"
},
"high" : {
"value" : 0,
"system" : "http://unitsofmeasure.org",
"code" : "wk"
}
}
}
],
"url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/relative-time"
}
],
"repeat" : {
"count" : 1
}
}
}